Experiences with the dihydropyridine calcium channel blocker amlodipine in hypertensive patients with chronic renal failure

被引：0
|
作者：
Légrády, P [1 ]
Abrahám, G [1 ]
Letoha, A [1 ]
Sonkodi, S [1 ]
机构：
[1] Univ Szeged, Dept Med 1, Szeged, Hungary
来源：
JOURNAL OF HYPERTENSION | 2003年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S192 / S192
页数：1
相关论文
共 50 条
  • [1] A DIFFERENT DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER IN HYPERTENSIVE PATIENTS WHO DEVELOPED PEDAL EDEMA ON DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER THERAPY
    Yuksel, A.
    Karagoz, A.
    Ucar, O.
    Aydogdu, S.
    Celik, A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 163 : S126 - S127
  • [2] The efficacy and safety of dihydropyridine calcium channel blockers in hypertensive patients: amlodipine place
    Lebedeva, M. V.
    Beketov, V. D.
    Maltsev, N. V.
    Safarova, M. E.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2013, 9 (01) : 86 - 89
  • [3] Mechanisms of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidence
    Mason, RP
    ATHEROSCLEROSIS, 2002, 165 (02) : 191 - 199
  • [4] Effects of amlodipine, a calcium channel blocker, on rat renal arterioles
    Kimura, K
    Suzuki, N
    Ohba, S
    Mise, N
    Miyashita, K
    Tojo, A
    Goto, A
    Omata, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1997, 58 (06): : 375 - 380
  • [5] The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan and a calcium channel blocker (amlodipine) in type 2 diabetic hypertensive patients: The OLCA study
    Daikuhara, Hiroyuki
    Kikuchi, Fumi
    Ishida, Toshihiko
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (04): : 280 - 286
  • [6] CALCIUM-CHANNEL BLOCKER NISOLDIPINE IN CHRONIC-RENAL-FAILURE
    BLAU, A
    HERZOG, D
    SHECHTER, P
    SACHS, D
    ELIAHOU, HE
    RENAL FAILURE, 1990, 12 (02) : 113 - 119
  • [7] EFFICACY AND SAFETY OF FELODIPINE, A NEW DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKER, IN ELDERLY HYPERTENSIVE PATIENTS
    DEQUATTRO, V
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1992, 14 (06) : 965 - 988
  • [8] The novel development of an experimental model of dihydropyridine calcium channel blocker poisoning using intravenous amlodipine
    Jang, David H.
    Donovan, Sean P.
    Bania, Theodore C.
    Nelson, Lewis S.
    Hoffman, Robert S.
    Chu, Jason
    CLINICAL TOXICOLOGY, 2012, 50 (07) : 697 - 697
  • [9] EFFECT OF OXODIPINE, A NOVEL DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKER, IN NEUROGENIC HYPERTENSIVE DOGS
    MONTASTRUC, P
    MONTASTRUC, JL
    DUBREUIL, J
    GALIANO, A
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1993, 321 : 57 - 62
  • [10] Calcium channel blocker overdose: Experience with amlodipine
    Ghosh, Supradip
    Sircar, Mrinal
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2008, 12 (04) : 190 - 193
12345